Pacira BioSciences, Inc. (PCRX): EPS (Diluted)
$0.16
Year ended 2025-12-31
-22.2%
3-year compound annual growth
-45.5%
5-year compound annual growth
+14.9%
10-year compound annual growth
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0.16 | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$2.15 | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $0.89 | +161.8% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $0.34 | -63.0% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $0.92 | -72.4% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $3.33 | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$0.27 | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$0.01 | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$1.07 | n/m | 2018-02-28, From 2017-01-01 |
| 2016-12-31 | -$1.02 | n/m | 2018-02-28, From 2016-01-01 |
| 2015-12-31 | $0.04 | n/m | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | -$0.39 | n/m | 2016-02-25, From 2014-01-01 |
| 2013-12-31 | -$1.93 | n/a | 2016-02-25, From 2013-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $0.16 | n/m |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $2.03 | -33.7% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | -$0.68 | n/m |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $0.93 | n/m |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $0.82 | -33.3% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $0.75 | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.73 | -7.0% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | -$5.83 | n/m |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | -$3.68 | n/m |
Compare PCRX, AMPH, SUPN, EBS side by side · Screen every company in Pharmaceutical Preparations ↗